Plasma levels of soluble Flt-1 and Tie-2 correlate with neovascularization in human carotid atherosclerotic plaques – a pilot study - Summary - MDSpire
Advertisement
Association of Plasma Soluble Flt-1 and Tie-2 Levels with Neovascularization in Atherosclerotic Carotid Plaques: A Preliminary Investigation
To determine whether circulating soluble Flt−1 (sFlt−1) and soluble Tie−2 (sTie−2) are associated with intraplaque neovascularization (IPN) in human carotid atherosclerotic plaques.
Approach:
Study Population: Forty-four patients with ≥50% carotid stenosis underwent carotid ultrasound and superb microvascular imaging (SMI); plasma was collected from 29 patients and carotid endarterectomy specimens were obtained from 11 for histology.
Measurement Techniques: IPN was quantified using SMI and histological analysis, while plasma levels of VEGF−A/B/C/D, Ang−2, sFlt−1, and sTie−2 were measured by immunoassays.
Data Analysis: Single-cell RNA-seq data from human carotid plaques were analyzed to map expression of FLT1, TEK, VEGFA, ANGPT1, and ANGPT2 to specific plaque cell populations.
Key Findings:
IPN was detected in 33 out of 44 (75%) patients, with a median of 4 neovessels (range 0–16).
Plasma sFlt−1 correlated with SMI neovessel counts (r=0.42, p=0.030), and sTie−2 showed a trend towards correlation (r=0.37, p=0.057).
In the surgical subgroup, histological neovessel counts correlated with sFlt−1 (r=0.65, p=0.030) and SMI neovessel count (r=0.68, p=0.02).
Log-sFlt−1 remained independently associated with SMI-derived neovessel counts after adjustment for age and BMI (B = 13.24, p=0.047).
No significant associations were found between IPN or sFlt−1/sTie−2 and conventional risk factors.
Interpretation:
Limitations:
The small sample size limits the generalizability of the findings.
The cross-sectional design does not establish causality.